MK
Mahesh Kumar Kantilal Bhalgat
About Mahesh Kumar Kantilal Bhalgat
Data last updated:
Mahesh Kumar Kantilal Bhalgat was a Whole-Time Director at Sanofi Healthcare India Private Limited (2015–2019), Director at Syngene Manufacturing Solutions Limited (2022–2024) and Additional Director at Veeda Clinical Research Limited (2024), and held 2 more directorships. The companies operate in Life Sciences, Chemicals and Materials and Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 29 Sep 2015 | 1993 | ₹1,726 Cr (FY 2025) | Active | |
| Director | 26 Aug 2022 | 2022 | ₹5.7 Lakh (FY 2026) | Under Liquidation | |
| Additional Director | 09 May 2024 | 2004 | ₹621 Cr (FY 2025) | Active | |
| Director | 10 Aug 2022 | 2022 | ₹334 Cr (FY 2025) | Active | |
| Additional Director | 14 Apr 2025 | 2021 | ₹30,000 (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mahesh Kumar Kantilal Bhalgat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mahesh Kumar Kantilal Bhalgat
Mahesh Kumar Kantilal Bhalgat was first appointed on 29 Sep 2015 as Whole-Time Director at Sanofi Healthcare India Private Limited. The most recent appointment on record is 14 Apr 2025 at Ingenuity Biosciences Private Limited.
Mahesh Kumar Kantilal Bhalgat held 5 earlier board appointments: Sanofi Healthcare India Private Limited (Whole-Time Director, 29 Sep 2015 to 30 Jun 2019); Syngene Manufacturing Solutions Limited (Director, 26 Aug 2022 to 31 Jan 2024); Veeda Clinical Research Limited (Additional Director, 09 May 2024 to 30 May 2024); Syngene Scientific Solutions Limited (Director, 10 Aug 2022 to 31 Jan 2024); Ingenuity Biosciences Private Limited (Additional Director, 14 Apr 2025 to 09 Jul 2025).